1. Home
  2. BVFL vs TLSA Comparison

BVFL vs TLSA Comparison

Compare BVFL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BVFL

BV Financial Inc.

N/A

Current Price

$21.50

Market Cap

176.4M

Sector

Finance

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

BUY

Current Price

$1.10

Market Cap

145.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BVFL
TLSA
Founded
1873
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.4M
145.1M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
BVFL
TLSA
Price
$21.50
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.97
AVG Volume (30 Days)
15.1K
★ 617.9K
Earning Date
10-16-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.19
N/A
EPS
★ 0.55
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.55
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.60
$0.76
52 Week High
$22.17
$2.33

Technical Indicators

Market Signals
Indicator
BVFL
TLSA
Relative Strength Index (RSI) 54.87 56.88
Support Level $20.36 $0.90
Resistance Level $21.85 $1.20
Average True Range (ATR) 0.52 0.10
MACD 0.04 0.02
Stochastic Oscillator 87.27 79.00

Price Performance

Historical Comparison
BVFL
TLSA

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: